New York State Common Retirement Fund Aldeyra Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 9,598 shares of ALDX stock, worth $40,983. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,598
Previous 18,598
48.39%
Holding current value
$40,983
Previous $62,000
16.13%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALDX
# of Institutions
116Shares Held
36.4MCall Options Held
196KPut Options Held
142K-
Perceptive Advisors LLC New York, NY9.28MShares$39.6 Million1.31% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$23.4 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$16.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$15.5 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.88MShares$8.03 Million0.24% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $249M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...